Wellgistics Health, Inc. has announced plans to integrate XRP cryptocurrency for conducting instant payments among its vast network. This initiative aims to optimize financial operations and modernize business transaction methods.
XRP Integration in Wellgistics Strategy
On July 24, 2025, Wellgistics Health, Inc. (NASDAQ: WGRX) revealed its intention to use XRP cryptocurrency and XRP Ledger (XRPL) for real-time payments and treasury reserves. The company plans to implement an XRPL-based platform for fast and cost-efficient transactions among 6,000 pharmacies and 150 manufacturers. This will significantly reduce payment processing times from 1–3 days for bank transactions to 3–5 seconds using XRP. CEO Brian Norton mentioned that the focus on infrastructure is crucial for the success of their healthcare payment system.
Capital and Treasury Strategy
The SEC filing explicitly recognizes XRP as a treasury asset. Wellgistics secured a $50 million equity line of credit for funding its XRP program. The company is permitted to issue shares as needed to raise capital. While Wellgistics contemplates the occasional sale of XRP holdings to meet tax or cash needs, the primary aim is to retain tokens as a reserve and collateral pool. By utilizing XRP, the company also plans to offer 'premiums' in the form of tokens as incentives for clients and partners.
Financial Position and Expert Opinion
Financially, Wellgistics remains in a precarious position. As of March 31, 2025, the company had $2.52 million in cash, while its total accumulated deficit reached $42.19 million. Recent concerns regarding the company’s financial reporting have arisen, with experts like former SEC official Marc Fagel questioning the necessity of healthcare startups holding significant cryptocurrency reserves and likening Wellgistics’ actions to pump-and-dump schemes in the crypto space.
The integration of XRP into Wellgistics Health's financial structure could potentially impact the healthcare sector by enhancing payment infrastructure. However, unstable financial metrics and critical commentary from experts raise doubts about the viability of this strategy.
